StockCIK 1728328
InMed Pharmaceuticals Inc. (INM): Insider Trades and Fund Holdings
In the past 12 months, InMed Pharmaceuticals Inc. insiders reported 15 open-market purchases worth $204K and 0 sales worth $0.
15Insider buys, 12 months
$204KBought by insiders, 12 months
$0Sold by insiders, 12 months
0Tracked funds holding
Recent insider trades
Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Oct 27, 2026.
| Filed | Insider | Type | Value |
|---|---|---|---|
| Oct 27 | Adar1 Capital Management, LLC10% owner | ▲ BUY | $5 |
| Oct 20 | Adar1 Capital Management, LLC10% owner | ▲ BUY | $1K |
| Oct 20 | Adar1 Capital Management, LLC10% owner | ▲ BUY | $1 |
| Oct 15 | Adar1 Capital Management, LLC10% owner | ▲ BUY | $11K |
| Oct 15 | Adar1 Capital Management, LLC10% owner | ▲ BUY | $1K |
| Oct 15 | Adar1 Capital Management, LLC10% owner | ▲ BUY | $750 |
| Oct 8 | Adar1 Capital Management, LLC10% owner | ▲ BUY | $7K |
| Oct 8 | Adar1 Capital Management, LLC10% owner | ▲ BUY | $4K |
| Oct 8 | Adar1 Capital Management, LLC10% owner | ▲ BUY | $3K |
| Oct 5 | Adar1 Capital Management, LLC10% owner | ▲ BUY | $24K |
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings
All 15 INM insider trades →Insiders who traded in the past year
| Insider | Role | Buys | Bought | Sells | Sold |
|---|---|---|---|---|---|
| Adar1 Capital Management, LLC | 10% owner | 15 | $204K | 0 | $0 |
Reading these numbers
Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →